How Can We Put COVID Behind Us Without Guaranteed Paid Sick Leave? March 31, 2022 Perspective KHN’s Céline Gounder and KFF’s Mollyann Brodie look at the challenges in returning to normal life after the COVID-19 pandemic when many Americans, particularly people of color and workers with low incomes, do not have paid sick leave.
Strategies To Lower Drug Costs Top the Public’s Health Priorities for Congress March 31, 2022 News Release Against the backdrop of public concern about inflation and rising gas prices, proposals to lower what people pay out-of-pocket for drugs tops the public’s list of health care priorities for Congress, a new KFF Health Tracking Poll finds. Most (55%) of the public say inflation is the biggest problem facing…
KFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities March 31, 2022 Poll Finding This poll finds the public’s health care priorities for Congress focus on reducing out-of-pocket costs, and concerns over inflation and the economy are top of mind as voters begin to think about the November midterm elections. The poll also examines views of the ACA and nursing homes.
Ending the HIV Epidemic (EHE) Funding Tracker March 29, 2022 Issue Brief This tracker provides up-to-date data on federal Ending the HIV Epidemic (EHE) funding, including an overview of funding mechanisms by year, agency, grant mechanism, and jurisdiction. It will be updated over time.
Many Uninsured People Could Lose Access to Free COVID-19 Testing, Treatment, and Vaccines as Federal Funding Runs Out March 28, 2022 News Release With an impasse in Congress over additional COVID-19 emergency funding, uninsured people could lose access to free testing and treatment services, a new KFF brief explains. For people without health insurance, the Health Resources and Services Administration (HRSA) COVID-19 Uninsured Program has reimbursed hospitals, doctors and other providers for the…
Implications of the Lapse in Federal COVID-19 Funding on Access to COVID-19 Testing, Treatment, and Vaccines March 28, 2022 Issue Brief A current impasse in Congress threatens continued funding for COVID-19 testing, treatment, and vaccines. The lack of additional federal COVID-19 funding has broad implications for access to these services, particularly for the uninsured, and could undermine efforts to ensure equitable access to these resources.
KFF COVID-19 Vaccine Monitor: Views on the U.S. Role In Global COVID-19 Response March 25, 2022 Poll Finding This Vaccine Monitor survey shows the public is largely supportive of the U.S. role in distributing COVID-19 vaccines globally, as well as other response efforts including the distribution of masks and COVID-19 rapid tests.
New KFF Analysis Finds That the U.S. Government Does Not Currently Have Enough Vaccine Doses to Fully Cover Every American with a 4th Dose March 25, 2022 News Release With funding for additional COVID-19 support at a stalemate in Congress, a new KFF analysis looks at potential scenarios that United States might face if a 4th COVID-19 vaccine dose is recommended to the public. The analysis finds that the U.S. government does not have enough funding to purchase vaccine…
Are There Enough COVID-19 Vaccines for America Without More Funding? March 25, 2022 Issue Brief This Data Note estimates how far the current U.S. supply of COVID-19 vaccines could stretch under different vaccination and booster scenarios. While estimated U.S. COVID-19 vaccine supply needs vary widely depending on assumptions and how many people choose to get vaccinated, this analysis indicates that under a plausible set of scenarios where 4th doses are recommended, the federal government is unlikely to have enough doses already purchased to cover the U.S. population.